Bromocriptine in peripartum cardiomyopathy: A meta‐analysis with trial sequential analysis
Abstract Bromocriptine has been proposed as a disease‐modifying therapy for peripartum cardiomyopathy (PPCM). The long‐term outcomes of bromocriptine use remain uncertain. We conducted a systematic review, meta‐analysis and trial sequential analysis (TSA) to assess the long‐term efficacy and safety...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2025-12-01
|
| Serie: | ESC Heart Failure |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1002/ehf2.70003 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|